2-Hydroxy-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-cyclopenta[e]benzofuran-8-yl]ethyl]-propanamide;2-Hydroxy-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-cyclopenta[e]benzofuran-8-yl]ethyl]-;2-hydroxy-N-(2-((S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propanamide;Ramelteon Impurity 19;Ramelteon Metabolite M-II (mixture of R and S at the hydroxy position);Ramelteon Metabolite M2;Propanamide, 2-hydroxy-N-[2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]-;(R,S)-hydroxy Ramelteon Metabolite M-II
It is a major metabolite of ramelteon and acts as a selective agonist at human melatonin receptors 1 and 2, with IC50 values of 208 pM and 1470 pM, respectively.